News & Blog
Venturing Israel’s Cybersecurity Landscape

Cybersecurity is one of the most attractive sectors in Israel, attracting roughly 35% of total global investments in the cyber space. With over 450 cybersecurity companies in Israel, investors can become overwhelmed as they attempt to navigate the landscape and understand differences between each company’s value proposition.
The Israeli ‘Second Act’

There are over 90 Israeli originated unicorns, majority of which are centered in B2B enterprises and cybersecurity. However, following 2022, the number of Israeli unicorns is on the decline. Israeli unicorns must begin to develop a strategy, or ‘Second Act’ that prolongs their high growth period which is critical for their success and valuation.
FUELING FAKE GROWTH

The investment landscape has become more complex with mid-stage companies showing inefficient growth despite achieving high sales volumes. Understanding which metrics are most reliable for validating sustainable growth are crucial for investors when evaluating growth investment opportunities.
Not an Art: Pricing of Securities on the Secondary Market

Recent financing rounds may provide a decent way to gauge security pricing yet they don't provide an accurate price for selling on the secondary market. Additional variables that affect the pricing of securities on the secondary market come into play when calculating stock pricing.
Dancing on Air

The decrease in valuations of public tech companies affects private transactions pricing, although the effects are not immediate. The immediate consequences include difficulty retaining employees, emergency cost cutting initiatives and an increased focus on profitability. VCs are adapting their strategies to reach the light at the end of the tunnel amidst market downturns.
Conflicts of Interest in Secondaries

GP-led secondary transactions have become increasingly popular and are gaining recognition as an active portfolio management tool. Often, a GP disposes fund assets in the secondary market by way of a stapled deal however, there arises a potential conflict of interest where the GP sells the assets at a discount. How can this conflict be avoided?